Skip to main content

Artemis Positive Future Fund update

The managers of the Artemis Positive Future Fund report on the fund over the quarter to 30 June 2023 and their views on the outlook.

Review of the quarter to 30 June 2023

  • During the quarter, we published the fund’s annual Impact Report, which analyses and measures the (positive) impact our holdings are making.
  • In a market led higher by a handful of mega-cap technology stocks, our pronounced bias towards mid-caps weighed on relative returns.
  • Recent multi-billion-dollar legal settlements have highlighted the financial opportunity for companies with the expertise needed to clean up PFAs (so-called ‘forever chemicals’).

Impact

During the quarter, we published the Artemis Positive Future strategy’s 2022 Impact Report. It demonstrates the ‘real-world’ impact our investments made in 2022 on a range of measures, from reduced emissions and cleaner water, through to better health and wider access to education.

front cover image impact report 2022 

You can read the full report (including independent, third-party quantification of strategy’s impact from the Upright Project) on our website, but the headline findings are that, for each £1 million pounds invested in our fund :

  • 1,100 tonnes of carbon dioxide emissions were saved, avoided or captured.
  • 40,000 litres of water were treated, saved or re-used.
  • 450,000 beverage containers were recycled.

In addition to the top-down view these headline impact statistics provide, this year’s report also explains how every company in our portfolio is contributing to building a positive future by providing a detailed appraisal of its impact, ESG performance and investment thesis.

The fund fell by 1.6% over the quarter…

… and so lagged a return of 3.3% from the benchmark MSCI AC World Index. In part, this was because a narrow group of mega-caps had an outsized influence on US market returns, with Nvidia, Meta, Apple and Microsoft outperforming significantly.

In addition, a number of style factors, most notably the significant underperformance of US small- and mid-caps, represented a significant headwind for our portfolio relative to the index and the peer group.

Strong returns from companies that can address pollution by ‘forever chemicals’.

We have written about the emerging pollution problem associated with PFAs (so-called ‘forever chemicals’) in Positive Sum, our impact investing blog (see The problem with PFAs for more details). During the quarter, two multi-billion-dollar legal settlements relating to contamination of drinking water by the manufacturers of PFAs drew fresh attention to the problem. DuPont, Chemours and Corteva came to a $1.85bn settlement; 3M reached a $10.3billion settlement. Both settlements related to just one application of PFAs: fire suppressants.

We believe this highlights the scale of the opportunity for PFA-remediation specialists such as Montrose Environmental Group, whose shares moved 15% higher in sterling terms on the quarter. Shares in engineering company Tetra Tech, which is also active in PFA clean up, ended the quarter 8% higher after it secured a large order from the US Army Corps of Engineers.

DISCO and Aehr Test Systems performed well.

Japan’s DISCO, whose tools and consumables are used for cutting, grinding and polishing semiconductors, returned 32% in sterling terms and made the single largest contribution to returns over the quarter. In part, that was a result of AI-related enthusiasm for semiconductor names and signs that consumer semiconductor market was bottoming out. Aehr Test, which makes equipment for testing a new generation of silicon carbide-based semiconductors, was also helped by increased appetite for semiconductor-related names and by strength in demand for electric vehicles.

Set against that, our renewable energy-related stocks saw (short-term) weakness.

Lower electricity prices and excess supply of solar panels from China weighed on the European market and on the share prices of some of our clean-energy related holdings including First Solar (down 15% in sterling terms) and SolarEdge (down 14%).

Earnings guidance from Alfen (down 18%) came in towards the low end of expectations due, in part, to a temporary slowdown in its EV charging business, which posed a (short-term) challenge to its valuation.

We established a new position in Motorola Solutions.

Motorola is the global leader in public safety systems and enterprise security solutions. Its land mobile radio network (LMR) offers a failsafe communication network for first responders during emergencies. Those systems are difficult to replicate or replace, giving Motorola a natural monopoly. Its long-term contracts with the US Federal government underpin its free cashflows, giving it capital to invest in reinforcing its position in the public-safety space.

We also added a new holding in Valmont.

Weather-related events are responsible for around 78% of major power outages in the US power system. Grid failures have huge social impacts, e.g. lack of access to potable water which fall most on low-income, uninsured individuals. Meanwhile, connecting renewables to the grid will be critical if the full potential of the Inflation Reduction Act (IRA) is to be realised. A 60% increase in transmission capacity will be required by 2030 to support clean energy development. US-listed Valmont is well-placed to profit; 40% of its sales are derived from electricity-grid infrastructure products. It is also seeing growing demand for its precision irrigation equipment and associated technologies in both the US and overseas (30% of sales).

We sold our holdings in Tesla, Vitasoy and STAAR Surgical.

Tesla was a beneficiary of a rally in consumer discretionary areas and AI-related speculation had created a valuation challenge. This, combined with the long-term risks to Tesla’s brand posed by Elon Musk’s increasingly erratic pronouncements, resulted in a full sale.

In the case of Vitasoy, results highlighted that its attempts to re-capturing lost market share in China are probably going to be a longer-term challenge than had been anticipated. We also sold Staar Surgical, the launch of whose implantable lens product in the US is now expected to be more challenging than previously expected, leading to higher sales and marketing costs – and slower revenue growth – over the coming quarters.

Past performance is not a guide to the future.
Source: Lipper Limited/Artemis from 31 March to 30 June 2023 for class I accumulation GBP.
All figures show total returns with dividends and/or income reinvested, net of all charges.
Performance does not take account of any costs incurred when investors buy or sell the fund.
Returns may vary as a result of currency fluctuations if the investor's currency is different to that of the class.
Classes may have charges or a hedging approach different from those in the IA sector benchmark.
Benchmarks: MSCI AC World NR. IA Global NR; A group of other asset managers’ funds that invest in similar asset types as this fund, collated by the Investment Association. These act as ‘comparator benchmarks’ against which the fund’s performance can be compared. Management of the fund is not restricted by these benchmarks.

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.